Value-Based Pricing: Examples of Healthcare System Reforms from the UK and US and Implications for Industry

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.26, Iss.4, 2012-08, pp. : 217-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The UK government wants to implement a value-based pricing system for drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 535, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

The UK's proposed value-based pricing under the spotlight

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

UK Office of Fair Trading wants value-based pricing of drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 527, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Value-based pricing hot at ISPOR

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Reflections on the Changing Face of German Pharmaceutical Policy: How Far is Germany from Value-Based Pricing?

By Gerber Andreas

PharmacoEconomics, Vol. 29, Iss. 7, 2011-07 ,pp. : 549-553

Adis International

Access to resources Recommend Favorite